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1. Introduction
   Diabetes mellitus is a chronic metabolic disorder caused 
by defective insulin secretion, resistance to insulin action, 
or a combination of both[1]. Hyperglycemia, an inevitable 
consequence of diabetes, is the source of most deleterious effects 
associated with this disease along with alteration in glucose and 
lipid metabolism and modification in liver enzyme levels. The 
treatment goals have evolved significantly over the past decades 
from preventing imminent mortality, to alleviating symptoms, to 
normalize glucose levels with the intent of forestalling diabetic 
complications. 
   It is the fact that diabetes can’t be cured completely as it has 
never been reported that someone had recovered totally from 
it. If it is so, then why to opt for the conventional antidiabetic 
drugs that are either expensive or often related with adverse 
effects[2]. Ayurvedic herbs provide better alternatives, owing to 
lesser side-effects and low cost[3]. World Health Organization has 
also substantiated the utilization of herbal remedies to combat 
diabetes[4]. 
   Tinospora cordifolia (Willd.) Miers (T. cordifolia), commonly 
known as Guduchi, is a highly potent herb used in Ayurveda 
to combat diabetes and keep the function of various organs 
in harmony. Various Ayurvedic texts and Nighantu (lexicons/
Ayurvedic materia medica) have described its anti-diabetic usages 
under various names viz. Pramehaghna, Pramehahara, Mehaghna 
and Mehahara[5-9]. Ayurvedic Pharmacopoeia of India has also 
cited its antidiabetic utility[10]. Tribals of Korkus (Melghat, 
Maharashtra, India) have been using the herb for polyuria, diabetes 
and fever[11]. Various dosage forms of Guduchi and wide array of 
its derived products (active, natural principles and crude extracts) 
have been mentioned/used in traditional system of medicine and 
have reported anti-diabetic activity experimentally or clinically 
in numerous scientific journals. These constituents directly or 
indirectly affect various metabolic cascades and influence the level 
of glucose.
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   Though plentiful researches were carried out during the past 
decades, only scattered information exploring its antidiabetic 
activity is accessible. The present review highlights the reported 
antidiabetic potential of the plant and to understand its probable 
mode of its action. 
2. Methodology
   Published information from several articles, of which few review 
articles and cross-references were collected. Recent developments 
in antidiabetic research on Tinospora, covering all available 
records and articles in Pubmed, Scopemed, Dhara online and other 
allied databases including fields of pharmacology, biomedicine and 
health were also rationally reviewed and taken into study for the 
report. The search criteria were restricted to the roles of plant in 
diabetes and related complications, by probing Ayurvedic claims 
in light of published experimental and clinical outcomes in this 
regard. 
3. Phytochemical antidiabetic virtues
   It has been reported to mediate its anti-diabetic potential 
through myriad of biologically active phytoconstituents isolated 
from different parts of plant, including alkaloids, tannins, cardiac 
glycosides, flavanoids, saponins and steroids[12,13]. These 
compounds have been reported to encompass different target 
activities in diabetic conditions, thus enabling the potential 
application in experimental and clinical research. The isoquinoline 
alkaloid rich fraction from stem, includes palmatine, jatrorrhizine, 
and magnoflorine which have been reported for insulin mimicking 
and insulin releasing effect both in vitro (using rat pancreatic 
β-cell line, RINm5F) and in vivo[14]. Another isoquinoline alkaloid 
‘berberine’ has been tested and used successfully in experimental 
and human diabetes. It lowers elevated glucose level as effectively 
as metformin. It also inhibits FOXO1, which integrates insulin 
signaling with mitochondrial function, thus improving hepatic 
metabolism during insulin resistance and metabolic syndrome. By 
adenosine monophosphate-activated protein kinase activation, it 
decreases the blood sugar and cholesterol level and maintains the 
blood pressure[15-18]. Besides, tinosporin, isocolumbin, palmatine, 
tinocordiside, cordioside and β-sitosterol compounds present in 
stem and root which are also reported to possess antidiabetic, 
antihyperlipidemic and antioxidant properties (Figure 1)[19]. 
4. Experimental studies
4.1. In vivo studies
   
   Pharmacological studies have proven in vivo antidiabetic potential 
of various extracts of T. cordifolia and shown in Table 1[20-48]. 
Aqueous extract of stem obtained from another species of Tinospora-
‘Tinospora crispa’ also reported to possess antihyperglycemic effect 
probably by stimulation of insulin release via modulation of β-cell 
and Ca2+ concentration[49]. Borapetoside C isolated from Tinospora 
crispa (5 mg/kg, i.p.) attenuated the elevated plasma glucose in 
diabetic mice, increased glucose utilization, delayed the development 
of insulin resistance and then enhanced insulin sensitivity. The 
activation of insulin-induced IR-Akt-GLUT2 expression in liver and 
the enhancement of insulin sensitivity may have contributed to the 
hypoglycemic action of borapetoside C[50]. 
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Figure 1. Phytochemical antidiabetic virtues of T. cordifolia.
   One Ayurvedic polyherbal formulation ‘Ilogen-Excel’, which 
contains T. cordifolia as one of the constituents, administered at 
the dose of 50 and 100 mg/kg for 60 d which has shown significant 
decrease in blood glucose levels and increase in plasma insulin, 
hepatic glycogen and total hemoglobin. The root extract of plant 
lowered the levels of glycosylated hemoglobin, plasma thiobarbituric 
acid reactive substances, hydroperoxides and ceruloplasmin in 
diabetic rats[51]. A herbomineral formulation ‘Hyponidd’ is reported 
for its hypoglycemic potential as well as antioxidant activity and 
the results are comparable with earlier reports on this plant[52]. 
Hypoglycemic activity of polyherbal formulation ‘Trasina’ is 
reported due to the superoxide dismutase (SOD) activity of pancreatic 
islet cells in the rats. The formulation induces a dose related decrease 
in hyperglycemia and augments islet SOD activity[53]. Another 
polyherbal Ayurvedic formulation of the plant, ‘Dihar’, showed 
significant antihyperglycemic, antihyperlipidemic and antioxidant 
effects in rats. There was a significant decrease in reduced 
glutathione, SOD, catalase levels and increase in thiobarbituiric acid 
reactive species levels in the liver[54].  
4.2. In vitro studies
   In Ehrlich ascites tumor cells model, water, ethanol and 
methanol extracts of the herb showed glucose uptake-stimulatory 
activity[55]. The leaf powder sample effectively absorbed glucose 
and retarded its diffusion across dialysis membrane. The maximal 
glucose diffusion retardation index was exhibited by it. All these 
mechanisms might create a concerted function in lowering the rate 
of glucose absorption so as to decrease postprandial blood glucose 
concentration[56]. Initiation and restoration of cellular defense 
anti-oxidant markers including SOD, glutathione peroxidase and 
glutathione, inhibition of glucose 6-phosphatase and fructose 1, 
6-diphosphatase, restoration of glycogen content in liver were 
reported in in vitro studies[39].
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Table 1
Antidiabetic pharmacological profile of T. cordifolia.
Part Extract Drug-induced diabetes 
(Animal model)
Dosage 
(mg/kg)
Treatment Effect Proposed mechanism/remarks References
Root
Aqueous Alloxan-rats 400.0
p.o. for 21-
120 d 
Antihyperglycemic 
Effects on key metabolic enzymes involved in carbohydrate metabolism, 
significant glycemic control in mild and moderate type diabetes
[20]
Aqueous Alloxan-rats - p.o. Hypoglycemic
Increases in body weight, total hemoglobin and hepatic hexokinase; 
decreases in hepatic glucose-6-phosphatase, serum acid phosphatase, 
alkaline phosphatase, and lactate dehydrogenase
[21]
Aqueous Alloxan-rats 400.0 - Hypoglycemic Its effect equivalent to only 1 IU/kg of insulin [22]
Alcoholic Alloxan-rats 100.0
p . o .  f o r  6 
weeks
Hypoglycemic To reduce blood and urine glucose levels and prevent weight loss [23]
Aqueous
Alloxan induced diabetic 
cataract-rats
400.0
p . o .  f o r  2 
months
Hypoglycemic
Decreases of 38.01% and 40.41% in serum glucose levels after 1 and 2 
month treatment, respectively
[24]
Alcoholic, aqueous Fasted albino rats - - Hypoglycemic
To reduce fasting blood glucose by initiating endogenous insulin secretion, 
glucose uptake, inhibition of peripheral glucose release
[25]
Aqueous Alloxan-rats 2.5, 5.0
p . o .  f o r  6 
weeks
Significant 
hypoglycemic action 
Reduction in serum and tissue cholesterol, phospholipids and free fatty 
acids.
[26]
Aqueous Streptozotocin-rats -
p . o .  f o r  6 
weeks
Significant 
antihyperglycemic
Significant reduction in blood and urine glucose [27]
Alcoholic Alloxan-rats 100.0
p . o .  f o r  6 
weeks
Significant 
antihyperglycemic, 
Normalized the antioxidant status of heart, brain, liver and kidney, restores 
the antioxidant defence
[28,29]
Aqueous, alcoholic 
Fasting and adrenaline induced 
hyperglycaemia-rabbits
- p.o. Hypoglycaemic Decreases the blood glucose level and increases glucose tolerance [15]
Stem
Methanol Aloxan and streptozotocin-rats 150.0 p.o.
Significant 
hypoglycaemic 
The extract without showing toxicity in acute toxicity study [30]
Hexane, ethyl acetate, methanol Streptozotocin-rats 250.0 p.o. for 100 d
Significant 
antihyperglycemic 
To decrease glycosylated hemoglobin level, reduce glucokinase and 
increased glucose-6-phosphatase activity, and to improve insulin 
secretagogue effect, insulin and C-peptide levels which shows β-cells 
regeneration capacity of extracts
 [31]
Methanol Normal and alloxan-rats 500.0
p . o .  f o r  6 
weeks
Significant 
hypoglycemic
Significant decreases in blood glucose, glycosylated hemoglobin and cholesterol 
(P<0.05); increases in body weight and protein (P<0.01), hepatic enzyme 
hexokinase activity increased, glucose-6-phosphatase and significant decrease in 
fructose 1, 6-biphosphatase 
[32]
Aqueous, alcoholic Streptozotocin-albino rats
200.0, 
400.0
p.o. for 30 d Antihyperglycemic 
To modulate renal tissue morphology and ameliorate activity of key 
gluconeogenic enzymes and to improve renal functions
 [33]
Ethanolic Fasted albino rats 250.0  p.o. for 1 d
Hypoglycemic 
action
About 30% reduction in blood sugar  [34]
Aqueous 
Adrenaline induced 
hyperglycaemia in rabbits
10.0 -
Antihyperglycemic 
effect 
To significantly inhibit hyperglycaemia [35]
Ethanolic Alloxan-rats 250.0
Single dose, 
p.o.
Hypoglycemic 
activity
Significant effect within 1 week  [36]
Aqueous, alcoholic Streptozotocin-albino rats
200.0, 
400.0
p.o. for 30 d Antihyperglycemic
Act by increasing hepatic glycogen synthase and decreasing glycogen 
phosphorylase activity
[37]
Ethyl acetate, dichloromethane, 
chloroform and hexane extracts 
Normal and glucose-loaded 
Wistar rats
15.0 p.o. Antihyperglycemic
Alpha glucosidase inhibitor, to inhibit the salivary and pancreatic amylase, 
thus effectively reducing increased postprandial glucose level
[38]
Isoquinoline alkaloid rich 
fraction
Normal and glucose-loaded 
Wistar rats
50.0, 
100.0, 
200.0
p.o. Antihyperglycemic Insulin-mimicking and insulin-releasing effect in vitro and in vivo [39]
Hydoalcoholic extraction (70% 
ethanol, 30% water)
High fat diet fed and 
streptozotocin-Sprague-
Dawley rats
100.0, 
200.0
p.o. for 14 d Antihyperglycemic
To mitigate oxidative stress, promote insulin secretion, inhibit 
gluconeogenesis and glycogenolysis
 [40]
Aqueous Alloxan induced diabetic rats 500.0 p.o. for 40 d Antihyperglycemic 
Significant decreases in blood glucose, glycosylated haemoglobin, urea, 
cholesterol (P<0.05), and increases in protein and glycogen (P<0.01), 
extract with nontoxic and well tolerated. 
[41]
Aqueous 
High-fructose diet (66% 
fructose) induced diabetic 
Wistar rats
400.0 p.o. for 60 d Antihyperglycemic 
To prevent rise in glucose levels by 21.3%, insulin by 51.5%, triglycerides 
by 54.12% and glucose-insulin index by 59.8%; to alleviate insulin 
resistance and oxidative stress; to improve glucose and lipid metabolism
[42,43]
Leaves
Aqueous, alcoholic, chloroform 
Normal and alloxan induced 
diabetes in rabbits
50.0, 100.0, 
200.0
p.o. for 1 d
Dose dependent 
hypoglyce mic
Action similar to glibenclamide and insulin [44]
Aqueous extracted saponarin, 
(alpha-glucosidase inhibitor)
Maltose-fed rats 20.0-80.0 p.o. Hypoglycemic 
To show saponarin (apigenin-6-C-glucosyl-7-O-glucoside) with competitive 
inhibition on activities of alpha-glucosidase and sucrase of different origins
 [45]
Whole 
plant
Alcoholic and aqueous Streptozotocin- mice 400.0 p.o. for 50 d Hypoglycemic Amelioration of diabetic neuropathy and gastropathy [46]
Aqueous Streptozotocin-mice 200.0 p.o. for 40 d Hypoglycemic
To reduce plasma glucose concentration by 7.45% through increasing 
glucose metabolism; to prevent polyuria, rise in urinary albumin levels and 
renal hypertrophy as well
 [47]
Aqueous Alloxan-rats and rabbits 400.0 p.o. Hypoglycemic To regulate glucose metabolism [48]
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5. Beneficial role in diabetic complications and related 
conditions
5.1. Diabetic retinopathy
   
   Plant extract (250 mg/kg for 24 weeks) in rats reduces 
blood glucose and inhibits over-expression of angiogenic and 
inflammatory mediators (angiogenic markers-vascular endothelial 
growth factor, protein kinase C and anti-inflammatory markers 
tumor necrosis factor alpha and interleukin-1 beta), which are 
distinct markers of diabetic retinopathy. Moreover, it also prevents 
retinal oxidative stress and restores antioxidant enzyme levels and 
provides evidence for its safety and efficacy in the management of 
experimental diabetic retinopathy[57]. 
5.2. Cataract
   
   Root extracts (400 mg/kg) prevented experimental diabetic 
cataract in rats. Total decrease of 38.01% in serum glucose levels 
after 1 month and decrease of 40.41% after 2 month of oral 
treatment were observed[24]. 
5.3. Diabetic neuropathy and gastropathy
   
   Stem extracts showed amelioration of experimental diabetic 
neuropathy and gastropathy in rats by oral administration[47]. 
Aqueous extract of stem prevented hyperalgesia in rats and showed 
aldose reductase inhibitory activity in vitro (with an IC50 of 103 
μg/mL)[58]. Clinical trials with aldose reductase inhibitor, sorbinil 
(Pfizer-CP45634) have demonstrated significant improvement 
in the pain relief, motor and sensory nerve conduction velocities 
with minimum toxicity in patients with neuropathy. Role of aldose 
reductase inhibitor in the treatment of symptomatic, somatic 
and autonomic neuropathies complicating diabetes has been 
established[59].
5.4. Diabetic nephropathy
   
   Plant extracts (200 mg/kg orally for 40 d) attenuated progression 
of renal damage and prevented polyuria, rise in urinary albumin 
levels and renal hypertrophy as well in mice[47]. Consumption of 
a diet containing Tinospora at the 5% level ameliorates changes in 
kidney chondroitin sulphate/dermatan sulphate in diabetic rats[60]. 
It was also found effective in modulation of morphology and some 
gluconeogenic enzymes activity in diabetic rat kidney[33].
5.5. Diabetic ulcers
   A randomized controlled study on plant extract as an adjuvant 
in surgical treatment of diabetic foot ulcers is proved to be highly 
beneficial in immunomodulation for ulcer healing. Thus, it speeds 
up the recovery[61]. 
5.6. Protection against brain, heart, liver and kidney damage 
in chronic diabetes
   The plant exerted neuro-protection by modulating the antioxidant 
system in rat hippocampal slices subjected to oxygen glucose 
deprivation. Its strong neuro-protective and free radical scavenging 
actions may be an effective therapeutic tool against ischemic and 
glucose deprived brain damage in chronic diabetes[62,63]. Alcoholic 
root extract has antioxidant defense mechanism in experimental 
rats. Root extract is reported to normalize the antioxidant status of 
heart, brain, liver and kidney at a dose of in alloxan-rats and the 
effect is more prominent than glibenclamide and insulin. Decreased 
concentrations of glutathione, glutathione peroxidase and SOD, 
catalase activity are reported in heart and brain of diabetes rats[25,26]. 
The cardioprotective activity of an herbal formulation “Caps HT2”, 
which contains methanol extract of Tinospora as a component, has 
shown antioxidant, anticoagulant, platelet anti-aggregatory, release of 
lipoprotein lipase, anti-inflammatory and hypolipidemic activity in 
rats[64]. 
5.7. Hyperlipidaemia
   
   Hyperglycemia and hyperlipidaemia coexists in diabetes. 
Administration of aqueous root extract in diabetic rats for 6 weeks 
results in a significant reduction of serum and tissue cholesterol, 
phospholipids and free fatty acids[23,26]. 
5.8. Weight loss
   
   Aqueous and alcoholic extract of root prevented weight loss and 
resulted in weight gain in rats[21,23].
5.9. Cardioprotective activity
   
   Ayurveda describes Hridya (cardioprotective) properties and its 
use in Hridroga (cardiac disorders)[8,9]. A dose-dependent reduction 
in infarct size and in serum and heart lipid peroxide levels was 
observed with treatment of T. cordifolia in ischemia-reperfusion-
induced myocardial infarction in rats[65]. The stem extract has been 
normalized alterations in the lipid metabolism caused by diabetes 
mellitus in streptozotocin-induced diabetic rats indirectly benefiting 
the heart[66]. 
5.10. Impotency and genitourinary troubles
   
   Impotency, erectile dysfunction and loss of libido are common 
complications in diabetes, affecting the person both medically 
as well as socially. Hydroalcoholic and aqueous extracts of stem 
(400 mg/kg body weight) showed significant aphrodisiac activity 
on male Wistar albino rats as evidenced by increase in number of 
mounts, penile erection index, ejaculatory behavior and mating 
performance. Stem extracts decreased blood urea concentration in 
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uremia, weight of ventral prostate, relieved urinary infections and 
dissolved urinary calculi[67,68]. Benefit in urinary tract infections 
does not have evidence of direct antibacterial action, but is likely 
to have a correlation with its anti-inflammatory and immune-
modulating activities.
5.11. Diabetic osteoporosis and anti-arthritic
   
   Nowadays osteoporosis and arthritis are also important issues in the 
milieu of frailty in elder diabetics. Bone loss in tibia slower than that 
in controls was demonstrated in rats treated with Tinospora extracts 
(10 mg/kg body weight), and showed osteoprotective effect. Serum 
osteocalcin and cross-laps levels were significantly reduced. This 
suggests its potential use as an anti-osteoporotic agent[69]. Aqueous 
extracts exerted a significant anti-inflammatory and analgesic effect 
on cotton pellet granuloma and formalin induced arthritis models. 
Its effect was comparable with indomethacin and its mode of action 
appeared to resemble that of a non-steroidal anti-inflammatory agent, 
which supports its usage in various painful arthritic conditions[70].
5.12. Gastrointestinal protection in old age
   Gastrointestinal troubles are common ailments in old age. 
Pharmacological evidences support the gastrointestinal protective role 
of Tinospora along with potential efficacy in relieving nonspecific 
diarrhea, dysentery, peptic ulcer and abdominal pain[71]. These studies 
can explain traditional claims of symptomatic relief in dyspepsia, 
belching, bloating, flatulence or stomach pain relating to term ‘Ajirna’ 
or ‘Agnimandya’ in Ayurvedic literature[72].
6. Role in gestational diabetes
   Gestational diabetes increases the incidences of congenital 
anomalies, morbidity, and mortality in the mother and her fetus/
newborn. In experimental diabetic rats, dietary supplements of 
the plant during pregnancy attenuated embryopathy and provided 
significant protection against diabetes-induced maternal and fetal 
oxidative stress. The plant extract significantly counterbalanced the 
diabetes-associated oxidative stress in maternal liver by lowering the 
levels of malondialdehyde and reactive oxygen species (in neutrophil 
cells) and the increased levels of glutathione and total thiols[73]. 
7. Clinical evidences
   The effect of the aqueous leaf digest (10 g/200 mL water) on post-
prandial blood glucose levels in type-2 diabetics was determined. 
The herb is found to exhibit a significant ability to reduce blood 
sugar levels in human subjects[74]. Its hypoglycaemic potential 
was substantiated by a similar response observed in another 
study, wherein two Ayurvedic dosages form viz. Guduchi Ghana 
(solidified aqueous extract) and Guduchi Satva (sedimented starchy 
aqueous extract) which exerted significant hypoglycemic and anti-
hyperglycaemic activity along with significant relief in signs and 
symptoms of type-2 diabetics. Statistically, Guduchi Ghana was 
proved to be more effective than Guduchi Satva to control glycemic 
level[75]. Two or more clinical studies reported on Kwatha (decoction) 
and Churna (fine powder) of Guduchi, also supports its antidiabetic 
potential[76,77]. Another clinical study has shown that Guduchi plays 
an important role in normalization of altered liver functions (alanine 
transaminase, aspartate transaminase) and the herb was found to be 
safe for therapeutic usage (dose: 500 mg/d, duration: 21 d, subjects: 
healthy individuals); thus via improving the function of hepar, the 
herb regulates the carbohydrate and lipid metabolism[78].  
   All these studies corroborate with the results of earlier animal 
studies and establish its use as a safe anti-diabetic agent in Ayurvedic 
system of medicine. 
8. Contemporary studies to decode the mode of action
   Tinospora is a renowned immunomodulator[79,80], adaptogenic[81], 
antioxidant[82], free radical scavenging[83], hepatoprotective and 
hormone regulation agent[84], proving it an preventive as well as 
curative anti-diabetic herb par excellence. Some of its activities via 
these peripheral mechanisms are detailed as follows.
8.1. Suppression of oxidative stress
   Hyperglycemia-induced oxidative stress promotes auto-oxidation 
of glucose to form free radicals. The generation of free radicals 
beyond the scavenging abilities of endogenous antioxidant defense 
may further result in macrovascular and microvascular dysfunctions 
in the body[85]. Activity of plant in countering oxidative stress is well 
established[74].
8.2. Immunomodulation to ameliorate diabetes
   Owing to the multifaceted immune modulatory potential, Tinospora 
has the ability to impact a plethora of diseases, including diabetes. 
Diabetes is accompanied by various autoimmune mechanisms, 
leading to progressive loss of pancreatic islet β cells[86]. During the 
initial phase of autoimmune destructive process, some viable β cells 
produce enough insulin. By time, nearly all β cells are destroyed and 
the patient becomes totally exogenous insulin dependent. Tinospora 
improves immuno response, by which the autoimmune process could 
be halted or reversed. Thus, several goals can be achieved including 
deactivation of islet-reactive lymphocytes, correction of inflammatory 
milieu that injures islets, promoting lymphocytic activation, and 
restoration of adequate islet mass. Immunomodulatory activity 
of plant is reported via various mechanisms, such as activation 
macrophages via Toll-like receptor 6 signaling, nuclear factor 
kappa-light-chain-enhancer of activated B cells translocation and 
cytokine production leading to increase in granulocyte-macrophage 
colony-stimulating factor, which leads to leukocytosis and improves 
neutrophil function[79,80,86].
8.3. Stress buster
   Stress and depression is an common occurrence in old age and it 
may sometimes unmask diabetes, by causing blood glucose levels 
to rise[87]. Mental stress can cause the imbalance of hormonal and 
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nervous regulation and make the susceptible to disorders including 
diabetes mellitus[88]. The herb is mentioned as a ‘Medhya Rasayana’ 
(memory enhancer) and for ‘Bhrama’ (vertigo) in Ayurveda. It is 
supported by current evidences that Tinospora exhibits anti-stress 
activity by normalization of stress-induced biochemical changes in 
norepinephrine, dopamine, and 5-hydroxytryptamine in experimental 
rat models and improves the level of 5-hydroxyindoleacetic acid 
(a metabolite of 5-hydroxytryptamine) in mice with ethanolic 
root extracts[89,90]. Depression is characterized by decreased 
levels of monoamines in brain like norepinephrine, serotonin, 
and dopamine. The mechanisms of anti-stress and antidepressant 
activities of Tinospora relate to interaction with alpha-1 adrenergic, 
dopaminergic (D2), serotonergic, and metabotropic transmembrane 
receptors for gamma-aminobutyric acid leading to increasing levels 
of norepinephrine, dopamine, serotonin, and gamma-aminobutyric 
acid. Potentiation of brain monoamines by inhibition of monoamine 
oxidase is another suggested mechanism proving it as an effective 
stress buster and restorer to health[91]. 
8.4. Nutritional supplementation 
   Along with rich protein and dietary fibre contents, appreciable 
levels of major and minor elements namely Zn, Mn, Cl, K, Ca, 
Ti, Cr, Fe, Co, Ni, Cu, Br, and Sr are found in this herb, which act 
as micronutrients for health restoration and alleviate degenerative 
processes in diabetes[92,93]. Crude values for food content in 
Tinospora include high fibre (15.19%), sufficient protein (4.5%-
11.2%), sufficient carbohydrate (61.66%), and low fat (3.1%). 
Nutritive value is 292.54 calories per 100 g. It has high potassium 
(0.845%) (regulatory function of nerve impulses), high chromium 
(0.006%) (regulation of carbohydrate utilization pathophysiological 
alterations in diabetes), sufficient iron (0.28%) (to improve 
haematopoietic functions especially in diabetic nephropathy where 
erythropoietin release from kidney is compromised), and sufficient 
calcium (0.131%) (regulatory functions in nervous, cardiovascular, 
and musculoskeletal systems)[94]. 
8.5. Raising life quality of diabetics
   The rejuvenating approach by its aforesaid properties might be 
linked to achieve better quality of life with increased life span in 
diabetics. Type 2 diabetes more typically develops with increasing 
age[95]. Senile dementia involves deteriorating effect on brain 
cells which reduces the life quality of diabetics. The usefulness 
of plant extracts as a cognitive enhancer is substantiated by its 
potent in vitro acetylcholinesterase inhibitory activity[96]. Its role in 
preventing oxidative stress associated with infections was suggested 
with reference to catalase, glutathione-s-transferase, glutathione 
peroxidase, glutathione reductase, SOD, and polyphenoloxidase[97]. 
Beside aforesaid activities, Tinospora also acts as hematinic, 
rejuvenator and tonic, which justify its beneficial role in general 
debility, fatigue, old age. 
9. Clinically desirable drug interactions 
   Although Tinospora is less likely to have drawbacks of the 
conventional drugs used for diabetes, the concepts of herb-drug 
interactions should also be kept in mind. No negative herb-drug 
interaction is reported till date, but more studies in this area remain 
yet to be accomplished. Concurrent administration of Tinospora 
with metformin showed beneficial pharmacokinetic as well as 
pharmacodynamic interaction leading to enhancing antihyperglycemic 
and antihyperlipidemic activities[98]. Plant alkaloid berberine has been 
shown to boost the effects of metformin and 2,4-thiazolidinedione, 
and can partly replace the commercial drugs, which could lead to a 
reduction in toxicity and side effects of the latter[99]. In Ayurveda, 
decoction of Tinospora stem is used as a medium of ‘Shodhana’ 
process (relates to combining a substance with another substance 
to enhance its activity and to help counter some of its unwanted 
effects) to purify Guggul (Commiphora wightii), which is an vital 
component of various Ayurvedic antidiabetic formulations. Tinospora 
enhanced the activity of Guggul. When used alone, the effect of 
Guggul significantly decreased. Use of Tinospora combinations has a 
potential basis for clinically desirable drug interactions[71,100,101]. 
10. Toxicity and safety concerns
   Although extensive works have been conducted on this herb, no 
conspicuous information on toxicity is available so far[102]. The herb 
is considered to be safe in dosage mentioned[103].  
11. Discussion
   Recent antidiabetic studies on Tinospora are consistent with its 
ancient and traditional use in diabetes. Current review outlined 
various pharmacological and clinical evidences which indicated that it 
had mild to moderate, but signiﬁcant, blood glucose lowering effect. 
The long-term use of its various extracts and dosage forms may be 
advantageous over chemical drugs in alleviating some of the chronic 
manifestations and complications caused by diabetes. Additionally, 
its use in conjunction with conventional drug treatments, such as a 
chemical agent or insulin, permits the use of lower doses of drug and/
or decreased frequency of administration which decreases the side 
effects most commonly observed.  
   In nutshell, Tinospora not only maintains glycemic control like 
those conventional drugs but possesses multiple target actions 
obliterating the complex diabetic pathology and remote apparent 
metabolic complications. Multiple sites of action of the plant were 
reported, such as liver, fat, pancreatic β cells, intestinal mucosa-L 
cells, muscle etc. It possesses multiple beneficial activities via several 
extrapancreatic (primarily) and intrapancreatic mechanisms attributed 
to improving the pathological status of diabetics. Its extrapancreatic 
activities such as glycogenesis/inhibited glycogenolysis in liver, 
improving glucose uptake and utilization, inhibiting gluconeogenesis, 
inhibiting intestinal glucose absorption, inhibiting α-glucoside and 
αα-amylase, mitigating oxidative stress, antioxidant properties and 
protection against tissue damage, seem to contribute profoundly to 
diabetes. The intrapancreatic actions involve preventing and restoring 
integrity and functioning of β cells, promoting endogenous insulin 
secretion/insulinotropic action and reduction of insulin resistance. 
Earlier studies reveal activities of its extracts in preventing, treatment 
or postponing the secondary diabetic complications. Thus, it works 
on all preventive, curative and restorative aspects of management, 
inevitably needed to counter diabetes. None of conventional 
synthetic drugs can provide all aforesaid beneficial properties. 
Present review warrants more investigation into the composition, 
isolation, purification, and characterization of bioactive products 
(active, natural principles, and crude extracts) to present in it for 
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identification of hypoglycaemic principles and to elucidate the 
biological roles of other herbs in this regard.
   Since the plant showed beneficial pharmacokinetic and 
pharmacodynamic interaction with synthetic antidiabetic drugs.
The dose and frequency of diabetes medication might need to 
be changed/trim down, as its administration along with diabetes 
medications might cause blood sugar to go too low. Blood sugar 
should be monitored closely. Tinospora in combination with 
other agents in Ayurvedic formulations has ‘Shodhana’ process 
(mentioned earlier) and supportive evidence from a modern 
pharmacological study[71,101]. Exploring the possibility of 
specific additive or synergistic effects of Tinospora with other 
substances and the pharmacokinetic and pharmacodynamics of such 
combinations will help to establish rationale behind combination 
formulations of Tinospora.
   Although evidence from animals and humans consistently 
supports the anti-diabetic claims of Tinospora in Ayurvedic 
literature, multi-centric large scale clinical trials would be more 
confirmatory, especially for in depth cause-effect evaluations, 
routing the mechanism of action and to evaluate the safety and 
interaction with conventional drugs when both are administered 
simultaneously. None of adverse reactions in the plant is found so 
far. Thus, it was been proved as a safe tool to manage diabetes. 
12. Perspectives and future directions 
   Tinospora must be thoroughly investigated in clinically manifested 
hyperglycaemia in the wake of ethnomedicinal antidiabetic usages. 
Studies on true dose response relationship of the action of the plant 
remain to be established. A consorted management approach by 
bridging Tinospora and synthetic drugs would be highly desirable, 
which will not only ensure good glycemic control when supported 
by suitable diet and life style regimen mentioned for diabetes, 
but also will aid to delay its complications. It can also be used as 
a supportive drug with other synthetic drugs as an adjuvant, to 
enhance their activity and to alleviate their possible side effects. 
   Future trials with similar antidiabetic herbs should be encouraged, 
and better identification criteria to screen the potential candidates 
for antidiabetic treatment should be established. It is a general 
belief that a synergism between two or more plant extracts 
enhances the physiological potential of bio-organic substances. A 
combination of different plant extracts is often preferred over single 
extract. Therefore, its extracts can be combined with other highly 
potent antidiabetic herbs such as Trigonella foenum graecum, 
Emblica officinalis, Momordica charantia etc. More in vivo and 
in vitro investigations should be encouraged in order to validate 
the antidiabetic activity of the identified plants claimed by the 
traditional healers and ancient literatures. Present review strongly 
emphasizes the optional and rational uses of traditional herbal 
medicines in this regard. 
   To our surprise, an integrated approach towards understanding 
the probable mode of action and elucidating mechanistic aspects 
of the herb is lacking. Without routing mechanism of action, it will 
be difficult for modern medicine to accept herbal formulations in 
mainstream therapeutics. Therefore, approaches for studying the 
effect of herbs should include the whole system, and mechanistic 
studies elucidating the multiple pharmaco-dynamic targets.
13. Conclusion
   Present review spotlights the classical antidiabetic claims of 
Tinospora and their validation by contemporary researches. 
Evidences from reported studies suggest its multi-faceted effects 
to prevent, reverse, or even delay the sequences of diabetes 
pathology via many overlapping extrapancreatic (primarily) 
and intrapancreatic mechanism of actions. Few tranditional and 
available management options are expensive and often associated 
with negative side effects. Therefore, Tinospora and analogous 
potent herbs provides better alternatives which have usually less 
toxic and affordable. This review can be used for further research as 
well as clinical purpose. 
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Comments 
Background
   Diabetes mellitus is the most common endocrine disorder of the 
world and one of the major risk factors for cardiovascular disease. 
Around 300 million population across the globe is expected to 
suffer from diabetes by the year 2025. Several anti-diabetic drugs 
are already in market which proves to be beneficial to these patients, 
but with the recent trends of over use of hypoglycemic drugs, the 
chances of resistance and complications arise. Moreover, the drugs 
dosage needs to be increased in patients due to its sensitivity and 
effectiveness in a long term use of one type of drug. So people 
are now switching to Ayurvedic and herbal medicines which 
have fewer side effects and are also cost effective with minimal 
contraindications. The current study is designed to evaluate the 
anti-diabetic properties of T. cordifolia which is quite promising 
reaseach studies conducted on its extracts (viz. immune modulatory, 
anti-hyperglycemic, antioxidant, adaptogenic, hepatoprotective, 
hormone regulator) and its phytoconstituents (like tinosporin, 
berberine, jatrorrhizine etc.) proving it as a preventive as well as 
curative anti-diabetic herb, which are substantiated by clinical trials. 
Research frontiers
   This is a review article, so no question of cutting edge research. It 
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is a combination of findings from research studies putting together 
in this paper.
Related reports
   Anti-diabetic properties of T. cordifolia have been documented 
since 2003. It is a review article written well by comprising of all 
the facts of T. cordifolia. 
Applications
   It is obvious that the extract of T. cordifolia can be used in several 
complications including diabetes.  
Peer review
   Over all, the paper is informative. This is worth to be published 
as the readers would be benefitted and learn the properties of T. 
cordifolia which is widely used as anti-diabetic medicine.
References
[1]    American Diabetes Association. Diagnosis and classification of diabetes 
mellitus. Diabetes Care 2009; 32(Suppl 1): S62–S67.
[2]    Dey L, Attele AS, Yuan CS. Alternative therapies for type 2 diabetes. 
Altern Med Rev 2002; 7: 45-58.
[3]    Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TP. Indian 
herbs and herbal drugs used for the treatment of diabetes. J Clin 
Biochem Nutr 2007; 40: 163-173.
[4]    Mandlik RV, Desai SK, Naik SR, Sharma G, Kohli RK. Antidiabetic 
activity of a polyherbal formulation (DRF/AY/5001). Indian J Exp Biol 
2008; 46: 599-606.
[5]    Acharya YT. Siddha Yoga Sangraha. Jwaradhikara. 13th ed. Nagpur: 
Baidyanath Ayurveda Bhavan Ltd; 2008, p. 4.
[6]    Acharya YT. Sushruta Samhita, Chikitsa Sthana. Reprint ed. Ch. 12, 
Verse 6. Varanasi: Chaukhambha Krishanadas Academy; 2004, p. 459. 
[7]    Tripathi I, editor. Chakradatta of Chakrapani Datta. Prameha Chikitsa. 
Ch. 35, Ver. 25, Reprint edition. Varanasi: Chaukhambha Sanskrit 
Sansthana; 1997, p. 217.
[8]    Chunekar KC, Pandey GS. Guduchyadi Varga. Bhavaprakash Nighantu. 
Varanasi: Chaukhamba Bharati Academy; 2006, p. 269.
[9]    Shastri P, editor. Sharangadhara Samhita of Sharangadhara. Madhyam 
Khanda. Ch. 1, Ver. 7, 7 ed. Varanasi: Chaukhamba Orientalia 
Prakashan; 2008, p.126.
[10]  Anonymous. The Ayurvedic Pharmacopoeia of India. Part 1, Vol 1. 1st 
ed. New Delhi: Govt. of India, Ministry of Health and Family Welfare; 
2001. p. 53.
[11]  Tambekar DH, Khante BS, Chandak BR, Titare AS, Boralkar SS, 
Aghadte SN. Screening of antibacterial potentials of some medicinal 
plants from Melghat forest in India. Afr J Tradit Complement Altern 
Med 2009; 6(3): 228-232.
[12]  Sudha P, Zinjarde SS, Bhargava SY, Kumar AR. Potent α-amylase 
inhibitory activity of Indian Ayurvedic medicinal plants. BMC 
Complement Altern Med 2011; 11: 5.
[13]  Rout GR. Identification of Tinospora cordifolia (Willd.) Miers ex Hook 
F & Thomas using RAPD markers. Z Naturforsch C 2006; 61(1-2): 
118-122.   
[14]  Patel MB, Mishra S. Hypoglycemic activity of alkaloidal fraction of 
Tinospora cordifolia. Phytomedicine 2011; 18: 1045-1052. 
[15]  Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, et al. Treatment of type 
2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J 
Clin Endocrinol Metab 2008; 93(7): 2559-2565. 
[16]  Yin J, Xingh H, Ye J. Efficacy of berberine in patients with type 2 
diabetes mellitus. Metabolism 2008; 57(5): 712-717.   
[17]  Cheng Z, Guo S, Copps K, Dong X, Kollipara R, Rodgers JT, et al. 
Foxo1 integrates insulin signaling with mitochondrial function in the 
liver. Nat Med 2009; 15(11): 1307-1311.
[18]  Sharma A, Batra A. Berberine a novel antidiabetic drug. Int J Res Rev 
Pharm Appl Sci 2013; 3(2): 216-230.
[19]  Gupta SS, Verma SC, Garg VP, Rai M. Anti-diabetic effects of 
Tinospora cardifolia. I. Effect on fasting blood sugar level, glucose 
tolerance and adrenaline induced hyperglycaemia. Indian J Med Res 
1967; 55: 733-745.
[20]  Grover JK, Vats V, Rathi SS. Anti-hyperglycemic effect of Eugenia 
jambolana and Tinospora cordifolia in experimental diabetes and their 
effects on key metabolic enzymes involved in carbohydrate metabolism. 
J Ethnopharmacol 2000; 73(3): 461-470.
[21]  Stanely P, Prince M, Menon VP. Hypoglycaemic and other related 
actions of Tinospora cordifolia roots in alloxan-induced diabetic rats. J 
Ethnopharmacol 2000; 70(1): 9-15. 
[22]  Dhaliwal KS, inventor. Method and composition for treatment of 
diabetes. United States patent US 5886029. 1999.
[23]  Prince PSM, Menon VP. Hypoglycaemic and hypolipidaemic action 
of alcohol extract of Tinospora cordifolia roots in chemical induced 
diabetes in rats. Phytother Res 2003; 17(4): 410-413.
[24]  Rathi SS, Grover JK, Vikrant V, Biswas NR. Prevention of experimental 
diabetic cataract by Indian Ayurvedic plant extracts. Phytother Res 
2002; 16(8): 774-777. 
Rohit Sharma et al./Asian Pac J Trop Biomed 2015; 5(1): 68-7876
[25]  George M, Venkatraman PR, Pandalai KM. Investigation on plant 
antibiotics, part II: A search for antibiotic substances in some Indian 
medicinal plants. J Sci Ind Res 1947; 3: 42-46.
[26]  Prince PSM, Menon VP, Gunasekaran G. Hypolipidaemic action of 
Tinospora cordifolia roots in alloxan diabetic rats. J Ethnopharmacol 
1999; 64: 53-57.  
[27]  Tomar A, Singh A, Thakur G, Agarwal AK, Singh VK. In vitro and 
in vivo study of Tinospora cordifolia as an antidiabetic agent in rat. 
Biochem Cell Biol 2010; 10: 175-177. 
[28]  Prince PSM, Kamalakkannan N, Menon VP. Restoration of 
antioxidants by ethanolic Tinospora cordifolia in alloxan-induced 
diabetic Wistar rats. Acta Pol Pharm 2004; 61: 283-287.  
[29]  Prince PSM, Padmanabhan M, Menon VP. Restoration of antioxidant 
defence by ethanolic Tinospora cordifolia root extract in alloxan-
induced diabetic liver and kidney. Phytother Res 2004; 18: 785-787.
[30]  Dhulia I, Parcha V, Pant G, Kumar D, Maithani A. Antihyperglycemic 
effect of methanolic extract of Tinospora cordifolia (Willd.) stem on 
experimentally induced diabetic rats. J Pharm Res 2011; 4(8): 2828-
2830.
[31]  Rajalakshmi M, Eliza J, Priya CE, Nirmala A. Daisy P. Anti-diabetic 
properties of Tinospora cordifolia stem extracts on streptozotocin-
induced diabetic rats. Afr J Pharm Pharmacol 2009; 3: 171-180.
[32]  Sivakumar V, Rajan MSD. Hypoglycemic and antioxidant activity 
of T. cordifolia in experimental diabetes. Int J Pharm Sci Res 2011; 
2(3): 608-613.
[33]  Puranik NK, Kammar KF, Devi S. Modulation of morphology and 
some gluconeogenic enzymes activity by Tinospora cordifolia 
(Willd.) in diabetic rat kidney. Biomed Res 2007; 18: 179-183. 
[34]  Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN, Ray C. Screening 
of Indian plants for biological activity: I. Indian J Exp Biol 1968; 6: 
232-247.
[35]  Raghunathan K, Sharma PV. Effect of Tinospora cordifolia Miers 
(Guduchi) on adrenaline induced hyperglycaemia. J Res Indian Med 
1969; 4(1): 59-62.
[36]  Kar A, Choudhary BK, Bandyopadhyay NG. Comparative evaluation 
of hypoglycaemic activity of some Indian medicinal plants in alloxan 
diabetic rats. J Ethnopharmacol 2003; 84(1): 105-108. 
[37]  Puranik N, Kammar KF, Devi S. Anti-diabetic activity of Tinospora 
cordifolia (Willd.) in streptozotocin diabetic rats; does it act like 
sulfonylureas? Turkish J Med Sci 2010; 40: 265-270.
 
[38]  Chougale AD, Ghadyale VA, Panaskar SN, Arvindekar AU. Alpha 
glucosidase inhibition by stem extract of Tinospora cordifolia. J 
Enzyme Inhib Med Chem 2009; 24: 998-1001. 
[39]  Patel MB, Mishra S. Hypoglycemic activity of alkaloidal fraction of 
Tinospora cordifolia. Phytomedicine 2011; 18: 1045-1052.  
[40]  Sangeetha MK, Balaji Raghavendran HR, Gayathri V, Vasanthi 
HR. Tinospora cordifolia attenuates oxidative stress and distorted 
carbohydrate metabolism in experimentally induced type 2 diabetes 
in rats. J Nat Med 2011; 65: 544-550.
[41]  Sivakumar V, Mohamed Sadiq A. Hypoglycemic activity of 
Tinospora cordifolia in Alloxan induced diabetic rats. The Bioscan 
2009; 4: 75-78.
[42]  Reddy SS, Ramatholisamma P, Karuna R, Saralakumari D. 
Preventive effect of Tinospora cordifolia against high-fructose diet-
induced insulin resistance and oxidative stress in male Wistar rats. 
Food Chem Toxicol 2009; 47(9): 2224-2229.  
[43]  Reddy SS, Ramatholisamma P, Ramesh B, Baskar R, Saralakumari 
D. Beneficiary effect of Tinospora cordifolia against high-fructose 
diet induced abnormalities in carbohydrate and lipid metabolism in 
Wistar rats. Horm Metab Res 2009; 41(10): 741-746.
[44]  Wadood N, Wadood A, Shah SA. Effect of Tinospora cordifolia on 
blood glucose and total lipid levels of normal and alloxan-diabetic 
rabbits. Planta Med 1992; 58(2): 131-136.  
[45]  Sengupta S, Mukherjee A, Goswami R, Basu S. Hypoglycemic 
activity of the antioxidant saponarin, characterized as alpha-
glucosidase inhibitor present in Tinospora cordifolia. J Enzyme Inhib 
Med Chem 2009; 24: 684-690. 
[46]  Grover JK, Rathi, SS, Vats V. Amelioration of experimental diabetic 
neuropathy and gastropathy in rats following oral administration 
of plants (Eugenia jambolana, Mucurna pruriens and Tinospora 
cordifolia) extracts. Indian J Exp Biol 2002; 40: 273-276.
[47]  Grover JK, Vats V, Rathi SS, Dawar R. Traditional Indian 
anti-diabetic plants attenuate progression of renal damage in 
streptozotocin induced diabetic mice. J Ethnopharmacol 2001; 76: 
233-238.
[48]  Raghunathan K, Sharma PV. The aqueous extract of T. cordifolia 
caused reduction of blood sugar in alloxan induced hyperglycemic 
rats and rabbits. J Res Ind Med 1969; 3: 203-209.
[49]  Noor H, Ashcroft SJ. Pharmacological characterisation of the 
antihyperglycaemic properties of Tinospora crispa extract. J 
Ethnopharmacol 1998; 62(1): 7-13.
Rohit Sharma et al./Asian Pac J Trop Biomed 2015; 5(1): 68-78 77
[50]  Ruan CT, Lam SH, Chi TC, Lee SS, Su MJ. Borapetoside C 
from Tinospora crispa improves insulin sensitivity in diabetic mice. 
Phytomedicine 2012; 19(8-9): 719-724. 
[51]  Umamaheswari S, Prince PSM. Antihyperglycaemic effect of ‘Ilogen-
Excel’, an ayurvedic herbal formulation in streptozotocin-induced 
diabetes mellitus. Acta Pol Pharm 2007; 64(1): 53-61.
[52]  Babu PS, Prince PSM. Antihyperglycaemic and antioxidant effect of 
hyponidd, an ayurvedic herbomineral formulation in streptozotocin-
induced diabetic rats. J Pharm Pharmacol 2004; 56: 1435-1442.
[53]  Bhattacharya SK, Satyan KS, Chakrabarti A. Effect of Trasina, an 
Ayurvedic herbal formulation, on pancreatic islet superoxide dismutase 
activity in hyperglycaemic rats. Indian J Exp Biol 1997; 35(3): 297-299.
[54]  Patel SS, Shah RS, Goyal RK. Antihyperglycemic, antihyperlipidemic 
and antioxidant effects of Dihar, a polyherbal ayurvedic formulation in 
streptozotocin induced diabetic rats. Indian J Exp Biol 2009; 47: 564-
570.
[55]  Joladarashi D, Chilkunda ND, Salimath PV. Glucose uptake-stimulatory 
activity of Tinospora cordifolia stem extracts in Ehrlich ascites tumor 
cell model system. J Food Sci Technol 2014; 51(1): 178-182.
[56]  Ahmed F, Siddaraju NS, Urooj A. In vitro hypoglycemic effects of 
Gymnema sylvestre, Tinospora cordifolia, Eugenia jambolana and Aegle 
marmelos. J Nat Pharm 2011; 2: 52-55.
[57]  Agrawal SS, Naqvi S, Gupta SK, Srivastava S. Prevention and 
management of diabetic retinopathy in STZ diabetic rats by Tinospora 
cordifolia and its molecular mechanisms. Food Chem Toxicol 2012; 50: 
3126-3132.
[58]  Nadig PD, Revankar RR, Dethe SM, Narayanswamy SB, Aliyar MA. 
Effect of Tinospora cordifolia on experimental diabetic neuropathy. 
Indian J Pharmacol 2012; 44: 580-583.
[59]  Jaspan J, Maselli R, Herold K, Bartkus C. Treatment of severely painful 
diabetic neuropathy with an aldose reductase inhibitor: relief of pain 
and improved somatic and autonomic nerve function. Lancet 1983; 2: 
758-762.
[60]  Joladarashi D, Chilkunda ND, Salimath PV. Tinospora cordifolia 
consumption ameliorates changes in kidney chondroitin sulphate/
dermatan sulphate in diabetic rats. J Nutr Sci 2012; 1: e7.
[61]  Purandare H, Supe A. Immunomodulatory role of Tinospora cordifolia 
as an adjuvant in surgical treatment of diabetic foot ulcers: a prospective 
randomized controlled study. Indian J Med Sci 2007; 61(6): 347-355.
[62]  Rawal A, Muddeshwar M, Biswas S. Effect of Rubia cordifolia, 
Fagonia cretica Linn, and Tinospora cordifolia on free radical 
generation and lipid peroxidation during oxygen-glucose deprivation in 
rat hippocampal slices. Biochem Biophys Res Commun 2004; 324(2): 
588-596.
[63]  Rawal AK, Muddeshwar MG, Biswas SK. Rubia cordifolia, Fagonia 
cretica linn and Tinospora cordifolia exert neuroprotection by 
modulating the antioxidant system in rat hippocampal slices subjected 
to oxygen glucose deprivation. BMC Complement Altern Med 2004; 4: 
11-19.
[64]  Mary NK, Babu BH, Padikkala J. Antiatherogenic effect of Caps HT2, 
a herbal Ayurvedic medicine formulation. Phytomedicine 2003; 10(6): 
474-482. 
[65]  Rao PR, Kumar VK, Viswanath RK, Subbaraju GV. Cardioprotective 
activity of alcoholic extract of Tinospora cordifolia in ischemia-
reperfusion induced myocardial infarction in rats. Biol Pharm Bull 
2005; 28: 2319-2322.
[66]  Nagaraja PK, Kammar KF, Sheela DR. Efficacy of Tinospora cordifolia 
(Willd.) extracts on blood lipid profile in streptozotocin diabetic rats. Is 
it beneficial to the heart? Biomed Res 2008; 19: 92-96.
[67]  Rai M, Gupta SS. Experimental evaluation of Tinospora cordifolia 
(Guduchi) for dissolution of urinary calculi. J Res Indian Med 1967; 
2(1): 115-116.
[68]  Gupta RS, Sharma A. Antifertility effect of Tinospora cordifolia 
(Willd.) stem extract in male rats. Indian J Exp Biol 2003; 41: 885-889.  
   
[69]  Kapur P, Jarry H, Wuttke W, Pereira BM, Seidlova-Wuttke D. 
Evaluation of the antiosteoporotic potential of Tinospora cordifolia in 
female rats. Maturitas 2008; 59: 329-338.
[70]  Utpalendu J, Chattopadhyay RN, Badri PS. Preliminary studies on 
anti-inflammatory activity of Zingiber officinale Rosc., Vitex negundo 
Linn. and Tinospora cordifolia (Willd) Miers in albino rats. Indian J 
Pharmacol 1999; 31: 232-233.
[71]  Kamble R, Sathaye S, Shah DP. Evaluation of antispasmodic activity 
of different Shodhit guggul using different shodhan process. Indian J 
Pharm Sci 2008; 70(3): 368-372.
[72]  Ayushveda. Dyspepsia (Ajirna) Ayurvedic treatment. India: Ayushveda 
Informatics. [Online] Available from: http://www.ayushveda.com/
health/dyspepsia.htm [Accessed on 28th March, 2011]
[73]  Shivananjappa MM, Muralidhara. Abrogation of maternal and fetal 
oxidative stress in the streptozotocin-induced diabetic rat by dietary 
supplements of Tinospora cordifolia. Nutrition 2012; 28: 581-587.
[74]  Sai KS, Srividya N. Blood glucose lowering effect of the leaves of 
Tinospora cordifolia and Sauropus androgynus in diabetic subjects. J 
Rohit Sharma et al./Asian Pac J Trop Biomed 2015; 5(1): 68-7878
Nat Remedies 2002; 2: 28-32.
[75]  Sharma R, Shukla VJ, Ravishankar B, Prajapati PK. The effect of 
two different dosage forms of Guduchi i.e. Satva and Ghana WSR 
antihyperglycemic effect on madhumeha (NIDDM) [dissertation]. 
Jamnagar: Gujarat Ayurveda University, IPGT and RA; 2012, p. 132-
133.  
[76]  Chakraborty SK, Barman NN. Clinical evaluation of Tinospora 
cordifolia (wild) Miers (Guduci) in the management of diabetic foot 
ulcer [dissertation]. Gauhati: University of Gauhati, Government 
Ayurvedic college; 2012. [Online] Available from: shodhganga.inflibnet.
ac.in:8080/jspui/bitstream/10603/27526/3/03_abstract.pdf [Accessed on 
4th December, 2014]
[77]  Kamini S. To study the effect of Guduchi Churna in Prameha 
[dissertation]. Nasik: Pune University; 2000.
[78]  Karkal YR, Bairy LK. Safety of aqueous extract of Tinospora cordifolia 
(Tc) in healthy volunteers: a double blind randomised placebo controlled 
study. Iran J Pharmacol Ther 2007; 6: 59-61.
[79]  Kapil A, Sharma S. Immunopotentiating compounds from Tinospora 
cordifolia. J Ethnopharmacol 1997; 58(2): 89-95.
[80]  Kalikar MV, Thawani VR, Varadpande UK, Sontakke SD, Singh RP, 
Khiyani RK. Immunomodulatory effect of Tinospora cordifolia extract 
in human immuno-deficiency virus positive patients. Indian J Pharmacol 
2008; 40: 107-110.
[81]  Rege NN, Thatte UM, Dahanukar SA. Adaptogenic properties of six 
rasayana herbs used in Ayurvedic medicine. Phytother Res 1999; 13(4): 
275-291.
[82]  Prince PSM, Menon VP. Antioxidant action of Tinospora cordifolia root 
extract in alloxan diabetic rats. Phytother Res 2001; 15(3): 213-218.
[83]  Prince PSM, Menon VP. Antioxidant activity of Tinospora cordifolia 
roots in experimental diabetes. J Ethnopharmacol 1999; 65(3): 277-281.
[84]  Bishayi B, Roychowdhury S, Ghosh S, Sengupta M. Hepatoprotective 
and immunomodulatory properties of Tinospora cordifolia in CCl4 
intoxicated mature albino rats. J Toxicol Sci 2002; 27(3): 139-146.
[85]  Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the 
pathogenesis of diabetic neuropathy. Endocr Rev 2004; 25(4): 612-628.
[86]  Harrison LC, Honeyman MC. Cow’s milk and type 1 diabetes: the real 
debate is about mucosal immune function. Diabetes 1999; 48: 1501-
1507.
[87]  Mitra A. Diabetes and stress: a review. Ethnomedicine 2008; 2(2): 131-
135.
 
[88]  American Diabetes Association. Stress. Alexandria: American Diabetes 
Association; 2013. [Online] Available from: http://www.diabetes.org/
living-with-diabetes/complications/mental-health/stress.html [Accessed 
on 15th March, 2014]
[89]  Patil M, Patki P, Kamath HV, Patwardhan B. Antistress activity of 
Tinospora cordifolia (wild) Miers. Indian Drugs 1997; 34: 211-215.
[90]  Sarma DN, Khosa RL, Chansauria JP, Ray AK. Effect of Tinospora 
cordifolia on brain neurotransmitters in stressed rats. Fitoterapia 1995; 
67(5): 421-422.
[91]  Dhingra D,  Goyal  PK.  Evidences  for  the  involvement  of 
monoaminergic and GABAergic systems in antidepressant-like activity 
of Tinospora cordifolia in mice. Indian J Pharm Sci 2008; 70(6): 761-
767.
[92]  Geeta K, Sharda K. Nutritional evaluation of Giloe (Tinospora 
cordifolia) extract incorporated energy dense food products. Indian J 
Res 2013; 2(9): 41-43. 
[93]  Nile SH, Khobragade CNN. Determination of nutritive value and 
mineral elements of some important medicinal plants from western part 
of India. J Med Plants 2009; 8: 79-88.
[94]  Madhav M, Maitreyee M. Tinospora cordifolia and its varied activities: 
what is believed and what is known? Int J Curr Res Rev 2011; 3(12): 94-
109.
[95]  Gambert S, Pinkstaff S. Emerging epidemic: diabetes in older adults: 
demography, economic impact, and pathophysiology. Diabetes Spectr 
2006; 19: 221-228. 
[96]  Vinutha B, Prashanth D, Salma K, Sreeja SL, Pratiti D, Padmaja R, et al. 
Screening of selected Indian medicinal plants for acetylcholinesterase 
inhibitory activity. J Ethnopharmacol 2007; 109(2); 359-363.
[97]  Manjusha GV, Rajathi K, Alphonse JKM, Meera KS. Antioxidant 
potential and antimicrobial activity of Andrographis paniculata and 
Tinospora cordifolia against pathogenic organisms. J Pharm Res 2011; 
4(2): 452-455.
[98]  Patwardhan B. The quest for evidence-based Ayurveda: lessons learned. 
Curr Sci 2012; 102(10): 1406-1417. 
[99] Prabhakar PK, Doble M. Synergistic effect of phytochemicals in 
combination with hypoglycemic drugs on glucose uptake in myotubes. 
Phytomedicine 2009; 16(12): 1119-1126.
[100] Lather A, Gupta V, Bansal P, Sahu M, Sachdeva K, Ghaiye P. An 
Ayurvedic polyherbal formulation Kaishore Guggulu: a review. Int J 
Pharm Biol Arch 2011; 2(1): 497-503.
[101] Caranasos GJ, Stewart RB, Cluff LE. Clinically desirable drug 
interactions. Annu Rev Pharmacol Toxicol 1985; 25: 67-95.
[102] Gupta AK, Gupta N, Sharma M, Indian Council of Medical Research. 
Quality standards of Indian medicinal plants. Vol. 1. New Delhi: Indian 
Council of Medical Research; 2003, p. 212.
[103] Upadhyay AK, Kumar K, Kumar A, Mishra HS. Tinospora cordifolia 
(Willd.) Hook. f. and Thoms. (Guduchi)-validation of the Ayurvedic 
pharmacology through experimental and clinical studies. Int J 
Ayurveda Res 2010; 1: 112-121.
